NEW YORK (GenomeWeb News) – Gen-Probe is spinning off its industrial testing assets into a new, independently operated company that will develop molecular assays for biopharmaceutical production, water and food safety testing, and other applications, the firm said today.

The new company will be called Roka Bioscience, and Gen-Probe will hold a 19.9 percent stake in the firm. It will begin operations as an independent entity immediately, with 18 Gen-Probe employees joining Roka.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.